UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2009, ISBN 0195328876, xiii, 368
Brain | Diagnostic Imaging | physiopathology | Imaging | methods | Aging | physiology | Geriatric neurology | Alzheimer's disease | Dementia | Neuroscientific Techniques | Development of the Nervous System | Vascular disease | Function | Dopamine | Mri | Prediction | Biochemistry | Diagnosis | Structure | Pet | Fmri
Book
2008, JKP essentials, ISBN 9781843108658, 159
Book
2014, ISBN 0812992962, xxvi, 417
Book
2009, 9th ed., ISBN 9780071499927, x, 1572, 46-1
Book
American journal of hematology, ISSN 0361-8609, 11/2017, Volume 92, Issue 11, pp. 1243 - 1259
Life Sciences & Biomedicine | Hematology | Science & Technology | Eosinophilia - therapy | Eosinophilia - etiology | World Health Organization | Humans | Risk | Disease Management | Eosinophilia - mortality | Eosinophilia - diagnosis | Practice Guidelines as Topic | Platelet-derived growth factor | Leukemia | Cytogenetics | Transplantation | Diagnosis | T cells | Hematopoietic stem cells | Public health | Corticoids | Imatinib | Eosinophilic leukemia | Leukocytes (eosinophilic) | Cytotoxicity | Hydroxyurea | Lymphocytes T | Hybridization | Eosinophilia | Patients | Hemopoiesis | α-Interferon | Chemotherapy | Interleukin 5 | Lymphocytes | Janus kinase 2 | Peripheral blood | Monoclonal antibodies | Fibroblast growth factor receptor 1 | Index Medicus
Journal Article
1998, 2nd ed., ISBN 9781853025556, xvi, 348
Book
American journal of hematology, ISSN 0361-8609, 03/2014, Volume 89, Issue 3, pp. 325 - 337
Eosinophilia - therapy | Humans | Risk | Antineoplastic Agents - therapeutic use | Myelodysplastic Syndromes - blood | Adrenal Cortex Hormones - therapeutic use | Hypereosinophilic Syndrome - etiology | Hypereosinophilic Syndrome - diagnosis | Myeloproliferative Disorders - blood | Flow Cytometry | Eosinophilia - genetics | Hypereosinophilic Syndrome - therapy | Eosinophilia - diagnosis | Myeloproliferative Disorders - diagnosis | World Health Organization | Hematopoietic Stem Cell Transplantation | Receptors, Platelet-Derived Growth Factor - genetics | In Situ Hybridization, Fluorescence | Bone Marrow Examination | Lymphoproliferative Disorders - blood | Heart Diseases - etiology | Myelodysplastic Syndromes - diagnosis | Clone Cells - pathology | Lymphoproliferative Disorders - diagnosis | T-Lymphocyte Subsets - pathology | Eosinophilia - classification | Oncogene Proteins, Fusion - genetics | Protein Kinase Inhibitors - therapeutic use | Hydroxyurea - therapeutic use | Hypereosinophilic Syndrome - genetics | Disease Management | Chemotherapy | Corticosteroids | Platelet-derived growth factor | Leukemia | Clinical trials | Cytogenetics | Hydroxyurea | Diagnosis | Biological response modifiers | T cells | Public health | Cancer | Index Medicus
Journal Article
American journal of hematology, ISSN 0361-8609, 10/2019, Volume 94, Issue 10, pp. 1149 - 1167
Life Sciences & Biomedicine | Hematology | Science & Technology | Eosinophilia - therapy | Prognosis | Humans | Middle Aged | Symptom Assessment | Male | Antineoplastic Agents - therapeutic use | Eosinophilia - epidemiology | Myelodysplastic Syndromes - blood | Adrenal Cortex Hormones - therapeutic use | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Young Adult | fms-Like Tyrosine Kinase 3 - genetics | Myeloproliferative Disorders - blood | Receptor, Platelet-Derived Growth Factor alpha - antagonists & inhibitors | Adult | Female | mRNA Cleavage and Polyadenylation Factors - genetics | Eosinophilia - diagnosis | Myelodysplastic Syndromes - drug therapy | mRNA Cleavage and Polyadenylation Factors - antagonists & inhibitors | Myeloproliferative Disorders - diagnosis | Hematologic Neoplasms - diagnosis | Eosinophilia - etiology | World Health Organization | Risk Assessment | Janus Kinase 2 - genetics | Immunophenotyping | In Situ Hybridization, Fluorescence | Myeloproliferative Disorders - drug therapy | Bone Marrow Examination | Myelodysplastic Syndromes - diagnosis | Clone Cells - pathology | Hematologic Neoplasms - blood | Oncogene Proteins, Fusion - genetics | Receptor, Platelet-Derived Growth Factor alpha - genetics | Hematologic Neoplasms - drug therapy | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Disease Management | Corticoids | Imatinib | Eosinophilic leukemia | Leukocytes (eosinophilic) | Stem cell transplantation | Cytotoxicity | Hydroxyurea | Hybridization | Eosinophilia | Hematopoietic stem cells | Hemopoiesis | Chemotherapy | Janus kinase 2 | Peripheral blood | Cytogenetics | Interferon | Diagnosis | Fibroblast growth factor receptor 1 | Index Medicus
Journal Article